We are live on
!
Find out more
Galectin Therapeutics
GALT
GALT
60 hedge funds and large institutions have $9.26M invested in Galectin Therapeutics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
7% more call options, than puts
Call options by funds: $185K | Put options by funds: $173K
0% more funds holding
Funds holding: 60 → 60 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0.69% less ownership
Funds ownership: 12.58% → 11.89% (-0.69%)
21% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 14
23% less capital invested
Capital invested by funds: $12M → $9.26M (-$2.76M)
Holders
60
Holders Change
–
Holders Change %
0%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
11
Reduced
14
Closed
5
Calls
$185K
Puts
$173K
Net Calls
+$12K
Net Calls Change
-$163K
Top Buyers
| 1 |
William Blair & Company
Chicago,
Illinois
|
+$58.8K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$26.8K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$21.5K |
| 4 |
HF
HRT Financial
New York
|
+$21.3K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$16.3K |
